Yahoo Finance

Solve M.E. Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs

LOS ANGELES, June 17, 2025 /PRNewswire/ -- Solve M.E. is proud to announce the second recipient of its 2025 ME/CFS Catalyst Award: Simmaron Research. Simmaron will receive targeted funding to ...
International Business Times

The Mission of Solve M.E.: Reframing the Response to ME/CFS and Long COVID

People who often experience overwhelming fatigue, unrefreshing sleep, cognitive difficulties, pain, and a variety of autonomic and sensory disturbances may be suffering from myalgic ...
Yahoo Finance

Solve M.E. Funds GLP-1 and Immune Target Studies to Accelerate ME/CFS and Long Covid Breakthroughs

LOS ANGELES, Feb. 24, 2026 /PRNewswire/ -- Solve M.E. is proud to support two pioneering studies through its ME/CFS Catalyst Awards. The first, led by Professor Carmen Scheibenbogen (Institute of ...
LA Weekly

How Emily Taylor Shaped Solve M.E.’s Catalyst Awards to Accelerate Breakthrough Research in ME/CFS and Long COVID

Solve ME/CFS Initiative’s (Solve M.E.) Catalyst Awards provide targeted funding to help studies in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long COVID, and related ...